GlassScriptPhysician profile
Michael Brian Jordan
NPI 1669537478
$61,210.26
in general payments reported to CMS, 2019-2025
5 companies · $987 in 2025
The $987 reported for 2025 was more than what a typical Pediatric Hematology-Oncology provider received nationally (typical 2025 total: $207).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $9,913 · 2021: $9,340 · 2022: $10K · 2023: $3,857 · 2024: $12K · 2025: $987.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $14K · Food and Beverage: $1,928 · Travel and Lodging: $651.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $13,800.00 |
| Food and Beverage | $1,928.08 |
| Travel and Lodging | $650.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sobi, INC | $45,835.88 | 2019-2025 | |
| Swedish Orphan Biovitrum Ab | $15,168.32 | 2020-2023 | |
| Boston Scientific Corporation | $102.65 | 2019-2024 | Lithovue, Lithoclast |
| Axonics, INC. | $62.32 | 2021-2022 | |
| Astellas Pharma US INC | $41.09 | 2023-2024 | Xtandi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Jordan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.